journal
Journals Journal of the National Compre...

Journal of the National Comprehensive Cancer Network : JNCCN

https://read.qxmd.com/read/38016284/the-nccn-2023-annual-congress-hematologic-malignancies
#1
JOURNAL ARTICLE
Crystal S Denlinger
No abstract text is available yet for this article.
November 25, 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935109/vitamin-d-insufficiency-as-a-risk-factor-for-paclitaxel-induced-peripheral-neuropathy-in-swog-s0221
#2
RANDOMIZED CONTROLLED TRIAL
Ciao-Sin Chen, Gary Zirpoli, William E Barlow, G Thomas Budd, Bryan McKiver, Lajos Pusztai, Gabriel N Hortobagyi, Kathy S Albain, M Imad Damaj, Andrew K Godwin, Alastair Thompson, N Lynn Henry, Christine B Ambrosone, Kathleen A Stringer, Daniel L Hertz
BACKGROUND: Prior work suggests that patients with vitamin D insufficiency may have a higher risk of chemotherapy-induced peripheral neuropathy (CIPN) from paclitaxel. The objective of this study was to validate vitamin D insufficiency as a CIPN risk factor. METHODS: We used data and samples from the prospective phase III SWOG S0221 (ClinicalTrials.gov identifier: NCT00070564) trial that compared paclitaxel-containing chemotherapy regimens for early-stage breast cancer...
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935108/referral-uptake-and-outcome-of-genetic-counseling-and-testing-in-patients-with-early-onset-colorectal-cancer
#3
JOURNAL ARTICLE
Hareem Syed, Joshua Sommovilla, Carol A Burke, Sarah McGee, Carole Macaron, Brandie Heald, Ruishen Lyu, Stephanie L Schmit, Kanika Nair, Suneel Kamath, Smitha Krishnamurthi, Alok A Khorana, David Liska
BACKGROUND: The incidence of early-onset colorectal cancer (EOCRC) is rapidly increasing. Pathogenic germline variants (PGVs) are detected in 16% to 20% of patients who have EOCRC, highlighting a need for genetic counseling (GC) and multigene panel testing in these patients. We aimed to determine the rate of referral to GC and uptake and outcomes of germline testing in patients with EOCRC. METHODS: We conducted a retrospective cohort study of patients aged <50 years diagnosed with colorectal cancer (CRC) from 2010 to 2019 at Cleveland Clinic...
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935107/mitigating-the-risk-of-aberrant-use-of-opioids-in-patients-with-cancer-pain
#4
JOURNAL ARTICLE
Marcin Chwistek
No abstract text is available yet for this article.
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935106/basal-cell-skin-cancer-version-2-2024-nccn-clinical-practice-guidelines-in-oncology
#5
JOURNAL ARTICLE
Chrysalyne D Schmults, Rachel Blitzblau, Sumaira Z Aasi, Murad Alam, Arya Amini, Kristin Bibee, Jeremy Bordeaux, Pei-Ling Chen, Carlo M Contreras, Dominick DiMaio, Jessica M Donigan, Jeffrey M Farma, Karthik Ghosh, Kelly Harms, Alan L Ho, John Nicholas Lukens, Lawrence Mark, Theresa Medina, Kishwer S Nehal, Paul Nghiem, Kelly Olino, Soo Park, Tejesh Patel, Igor Puzanov, Jason Rich, Aleksandar Sekulic, Ashok R Shaha, Divya Srivastava, Valencia Thomas, Courtney Tomblinson, Puja Venkat, Yaohui Gloria Xu, Siegrid Yu, Mehran Yusuf, Beth McCullough, Sara Espinosa
Basal cell carcinoma (BCC) is the most common form of skin cancer in the United States. Due to the high frequency, BCC occurrences are not typically recorded, and annual rates of incidence can only be estimated. Current estimated rates are 2 million Americans affected annually, and this continues to rise. Exposure to radiation, from either sunlight or previous medical therapy, is a key player in BCC development. BCC is not as aggressive as other skin cancers because it is less likely to metastasize. However, surgery and radiation are prevalent treatment options, therefore disfigurement and limitation of function are significant considerations...
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935105/should-we-use-comm-current-opioid-misuse-measure-to-screen-for-opioid-abuse-in-patients-with-cancer-pain
#6
JOURNAL ARTICLE
Natalie Moryl, Tito R Mendoza, Susan D Horn, Jelyn C Eustaquio, Charles S Cleeland, Charles Inturrisi
BACKGROUND: Growing concerns about opioid use disorder (OUD) and the resulting decrease in opioid availability for patients with cancer pain highlight the need for reliable screening tools to identify the subset of patients at increased risk for aberrant opioid use. Our study examines the utility of Current Opioid Misuse Measure (COMM) recommended by the NCCN Clinical Practice Guidelines in Oncology for Adult Cancer Pain. PATIENTS AND METHODS: We analyzed prospectively collected patient-reported outcomes of 444 consecutive patients with cancer seen in pain clinics of a cancer center at 2 time points within 100 days...
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935101/acute-and-chronic-complications-after-treatment-of-locoregional-anal-cancer-prevention-and-management-strategies
#7
REVIEW
Leah Katz, David P Horowitz, Lisa A Kachnic
Definitive chemoradiotherapy (CRT) for anal cancer spares patients the morbidity of a colostomy surgery and optimizes cancer outcomes. CRT, however, has introduced a unique acute and chronic toxicity profile, which has greatly improved over the years with the introduction of advanced radiotherapy techniques. This article provides the multidisciplinary care team with practical tools to mitigate and manage acute and chronic complications from definitive treatment of anal cancer.
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935100/association-between-pretreatment-chest-imaging-and-immune-checkpoint-inhibitor-pneumonitis-among-patients-with-lung-cancer
#8
JOURNAL ARTICLE
Alexander Wong, Maria Riley, Songzhu Zhao, Jessica Zimmer, Matthew Viveiros, Jing Gennie Wang, Vincent Esguerra, Mingjia Li, Gabrielle Lopez, Kari Kendra, David P Carbone, Kai He, Asrar Alahmadi, Jacob Kaufman, Regan M Memmott, Peter G Shields, Jeremy Brownstein, Karl Haglund, Meng Welliver, Gregory A Otterson, Carolyn J Presley, Lai Wei, Dwight H Owen, Kevin Ho
BACKGROUND: Immune checkpoint inhibitors (ICIs) are a first-line and perioperative treatment for lung cancer. Pneumonitis is a potentially life-threatening complication of ICI treatment in 2% to 5% of patients; however, risk factors for developing ICI pneumonitis (ICI-p) remain undefined. METHODS: We conducted a retrospective cohort study of consecutive patients with lung cancer who received at least one dose of ICI from 2015 through 2020 at The Ohio State University...
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935099/smoking-cessation-and-pancreatic-cancer-risk-in-individuals-with-prediabetes-and-diabetes-a-nationwide-cohort-study
#9
JOURNAL ARTICLE
Joo-Hyun Park, Jung Yong Hong, Jay J Shen, Kyungdo Han, Young Suk Park, Joon Oh Park
BACKGROUND: Individuals with diabetes and prediabetes are at increased risk of pancreatic cancer. However, little is known about the effects of smoking or smoking cessation on pancreatic cancer risk in individuals with diabetes and prediabetes. We investigated the association between smoking status (particularly smoking cessation) and pancreatic cancer risk according to glycemic status. PATIENTS AND METHODS: This nationwide cohort study included 9,520,629 adults without cancer who underwent the Korean National Health Screening in 2009 and were followed until 2018...
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935098/nccn-guidelines%C3%A2-insights-b-cell-lymphomas-version-6-2023
#10
JOURNAL ARTICLE
Andrew D Zelenetz, Leo I Gordon, Jeremy S Abramson, Ranjana H Advani, Babis Andreadis, Nancy L Bartlett, L Elizabeth Budde, Paolo F Caimi, Julie E Chang, Beth Christian, Sven DeVos, Bhagirathbhai Dholaria, Luis E Fayad, Thomas M Habermann, Muhammad Saad Hamid, Francisco Hernandez-Ilizaliturri, Boyu Hu, Mark S Kaminski, Yasmin Karimi, Christopher R Kelsey, Rebecca King, Susan Krivacic, Ann S LaCasce, Megan Lim, Marcus Messmer, Mayur Narkhede, Rachel Rabinovitch, Praveen Ramakrishnan, Erin Reid, Kenneth B Roberts, Hayder Saeed, Stephen D Smith, Jakub Svoboda, Lode J Swinnen, Joseph Tuscano, Julie M Vose, Mary A Dwyer, Hema Sundar
Novel targeted therapies (small molecule inhibitors, antibody-drug conjugates, and CD19-directed therapies) have changed the treatment landscape of relapsed/refractory B-cell lymphomas. Bruton's tyrosine kinase (BTK) inhibitors continue to evolve in the management of mantle cell lymphoma (MCL), in both the relapsed/refractory and the frontline setting. Anti-CD19 CAR T-cell therapies are now effective and approved treatment options for relapsed/refractory follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), and MCL...
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935097/letter-to-the-editor-disaggregating-asian-prostate-cancer-cohorts-can-help-us-improve-care-for-all-patients-with-prostate-cancer
#11
JOURNAL ARTICLE
David-Dan Nguyen, Jethro C C Kwong, Alexandre R Zlotta, Christopher J D Wallis
No abstract text is available yet for this article.
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935096/associations-between-surrogates-decisional-regret-trajectories-and-bereavement-outcomes
#12
JOURNAL ARTICLE
Fur-Hsing Wen, Chia-Hsun Hsieh, Wen-Chi Shen, Ming-Mo Hou, Po-Jung Su, Wen-Chi Chou, Jen-Shi Chen, Wen-Cheng Chang, Siew Tzuh Tang
BACKGROUND: Family surrogates experience heterogeneous decisional regret and negative long-lasting postdecision impacts. Cross-sectional findings on the associations between decisional regret and surrogates' bereavement outcomes are conflicting and cannot illustrate the directional and dynamic evolution of these associations. In this study, we sought to longitudinally examine the associations between 4 previously identified decisional-regret trajectories and bereavement outcomes among family surrogates of terminally ill patients with cancer...
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935095/authors-reply-to-the-letter-to-the-editor-by-nguyen-et-al
#13
JOURNAL ARTICLE
Xudong Ni, Yao Zhu
No abstract text is available yet for this article.
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37935094/giving-thanks
#14
JOURNAL ARTICLE
Margaret Tempero
No abstract text is available yet for this article.
November 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37879366/letter-to-the-editor-re-influence-of-food-with-different-fat-concentrations-on-alectinib-exposure-a-randomized-crossover-pharmacokinetic-trial
#15
LETTER
Andrew D Frugé, Kristen S Smith, Sylvia L Crowder, Wendy Demark-Wahnefried
No abstract text is available yet for this article.
October 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37856228/it-just-keeps-getting-better
#16
JOURNAL ARTICLE
Margaret Tempero
No abstract text is available yet for this article.
October 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37856227/letter-to-the-editor-inclusive-and-adequate-care-overcoming-all-health-care-gaps-the-need-to-specifically-look-to-the-lgbtqi-population
#17
JOURNAL ARTICLE
Massimo De Martinis, Lia Ginaldi
No abstract text is available yet for this article.
October 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37856226/machine-learning-based-early-warning-systems-for-acute-care-utilization-during-systemic-therapy-for-cancer
#18
JOURNAL ARTICLE
Robert C Grant, Jiang Chen He, Ferhana Khan, Ning Liu, Sho Podolsky, Yosuf Kaliwal, Melanie Powis, Faiyaz Notta, Kelvin K W Chan, Marzyeh Ghassemi, Steven Gallinger, Monika K Krzyzanowska
BACKGROUND: Emergency department visits and hospitalizations frequently occur during systemic therapy for cancer. We developed and evaluated a longitudinal warning system for acute care use. METHODS: Using a retrospective population-based cohort of patients who started intravenous systemic therapy for nonhematologic cancers between July 1, 2014, and June 30, 2020, we randomly separated patients into cohorts for model training, hyperparameter tuning and model selection, and system testing...
October 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37856224/-coming-full-circle-reintroduction-of-radiotherapy-delaying-chemotherapy-followed-by-craniospinal-radiotherapy-for-infants-with-medulloblastoma
#19
JOURNAL ARTICLE
Nicholas G Gottardo
No abstract text is available yet for this article.
October 2023: Journal of the National Comprehensive Cancer Network: JNCCN
https://read.qxmd.com/read/37856223/reply-to-the-letter-to-the-editor-by-frug%C3%A3-et-al
#20
JOURNAL ARTICLE
Daan A C Lanser, Anne-Marie C Dingemans, Ron H J Mathijssen, G D Marijn Veerman
No abstract text is available yet for this article.
October 2023: Journal of the National Comprehensive Cancer Network: JNCCN
journal
journal
40348
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.